NCT01182623

Brief Summary

It is current practice to remove any polyps found during colonoscopy. This is because adenomatous polyps have the potential to turn into cancer. However, a proportion of polyps \<10mm in size are hyperplastic, which cannot turn into cancer. Current practice requires these to be removed, as it is traditionally felt that they cannot be separated clinically from adenomas. This increases the risk of perforation and results in a significant cost in processing the samples. However, it has been suggested that it is possible to differentiate neoplastic from non neoplastic lesions using skills in polyp surface pattern recognition. If this is the case the investigators may be able to reduce the need for polypectomy The investigators believe that it is possible to tell the difference between polyps with cancerous potential and those that are harmless by assessment of surface patterns. This may enable us to improve the investigators clinical decisions when assessing polyps during colonoscopy, and reduce the number of unnecessary polypectomys being performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2010

Completed
Last Updated

April 10, 2023

Status Verified

April 1, 2023

Enrollment Period

10 months

First QC Date

August 12, 2010

Last Update Submit

April 6, 2023

Conditions

Keywords

FICEChromoendoscopyColonic polypsAdenomasHyperplastic polyps

Outcome Measures

Primary Outcomes (1)

  • The accuracy of predicted in-vivo polyp histology

    9 months

Secondary Outcomes (7)

  • • Sensitivity of white light endoscopy in predicting histology

    9 months

  • specificity of white light endoscopy in predicting histology

    9 months

  • Sensitivity of Chromoendoscopy in predicting histology

    9 months

  • Specificity of Chromoendoscopy in predicting histology

    9 months

  • Sensitivity of fujinon intelligent color enhancement (FICE) in predicting histology

    9 months

  • +2 more secondary outcomes

Study Arms (1)

In vivo diagnosis

Patients undergoing colonoscopy where one or more polyps up to 10mm in size are found.

Other: Observation of surface patterns of polyps

Interventions

examination of the surface patterns of polyps using FICE and indigo carmine dye spray

In vivo diagnosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing colonoscopy where one or more polyps are found.

You may qualify if:

  • Patients found to have polyps up to 10 mm in size

You may not qualify if:

  • Patient preference Clinicians judgement Obvious cancers Ulcerated polyps

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Portsmouth Hospitals NHS trust

Portsmouth, Hampshire, PO6 3LY, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

All polyps are sent for histological analysis as per standard protocol. This is not additional for the study and part of routine NHS practice. They will be kept and stored as per standard NHS protocols.

MeSH Terms

Conditions

Colonic PolypsAdenoma

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Pradeep Bhandari, MBBS,MD,MRCP

    Consultant gastroenterologist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2010

First Posted

August 17, 2010

Study Start

December 1, 2009

Primary Completion

September 30, 2010

Study Completion

September 30, 2010

Last Updated

April 10, 2023

Record last verified: 2023-04

Locations